These results show that RECQL4 variants could restrict BLM helicases in the cytoplasm of human glioma cells undergoing DNA damage preventing their action in DNA repair and translocation to DSB sites, indicated by the γH2AX foci. Here, RECQL4 is linked to central nervous system cancer.